Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice
Authors:
Open Access
- 17 January 2014
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 4 (1) , 3754
Abstract
Human ApoE4 accelerates memory decline in ageing and in Alzheimer's disease. Although intranasal insulin can improve cognition, this has little effect in ApoE4 subjects. To understand this ApoE genotype-dependent effect, we examined brain insulin signaling in huApoE3 and huApoE4 targeted replacement (TR) mice. At 32 weeks, lower insulin receptor substrate 1 (IRS1) at S636/639 and Akt phosphorylation at T308 were detected in fasting huApoE4 TR mice as compared to fasting huApoE3 TR mice. These changes in fasting huApoE4 TR mice were linked to lower brain glucose content and have no effect on plasma glucose level. However, at 72 weeks of age, these early changes were accompanied by reduction in IRS2 expression, IRS1 phosphorylation at Y608, Akt phosphorylation at S473, and MAPK (p38 and p44/42) activation in the fasting huApoE4 TR mice. The lower brain glucose was significantly associated with higher brain insulin in the aged huApoE4 TR mice. These results show that ApoE4 reduces brain insulin signaling and glucose level leading to higher insulin content.Keywords
This publication has 71 references indexed in Scilit:
- Cognition, glucose metabolism and amyloid burden in Alzheimer's diseaseNeurobiology of Aging, 2012
- Lifespan brain activity, β-amyloid, and Alzheimer's diseaseTrends in Cognitive Sciences, 2011
- Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamusPhysiology & Behavior, 2011
- Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide ClearanceScience Translational Medicine, 2011
- Resistin Promotes Cardiac Hypertrophy via the AMP-activated Protein Kinase/Mammalian Target of Rapamycin (AMPK/mTOR) and c-Jun N-terminal Kinase/Insulin Receptor Substrate 1 (JNK/IRS1) PathwaysJournal of Biological Chemistry, 2011
- Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 DiabetesArchives of Neurology, 2011
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recyclingProceedings of the National Academy of Sciences, 2010
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- The insulin paradox: aging, proteotoxicity and neurodegenerationNature Reviews Neuroscience, 2008
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993